Low Risk Differentiated Thyroid Cancer: Clinical Trials

2 trials for Low Risk Differentiated Thyroid Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Low Risk Differentiated Thyroid Cancer: new trials by email Literature Review of Low Risk Differentiated Thyroid Cancer trials Research Report on Low Risk Differentiated Thyroid Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
Shared-care model - Low Risk Differentiated Thyroid Cancer
UnknownNova Scotia Health Authority602022-09-302024-08-21
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
rhTSH stimulation, I131, Follow up - Low Risk Differentiated Thyroid Cancer
Phase 3Active not recruitingGustave Roussy, Cancer Campus, Grand Paris7762013-05-132023-05-17

Narrower conditions

Thyroid Neoplasms (1)

Broader conditions

Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Thyroid Diseases (1)

Interventions

Iodine-131 (1)  ·  Thyrotropin Alfa (1)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Nova Scotia Health Authority (1)

Countries

Canada (1)  ·  France (1)

Top investigators

Syed A. Imran, Dr. (1)

Results publications

PMID 35263518, PMID 39586309